Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2018   |   Volume: 7   |   Issue: 3   |   Page: 87-89     View issue

Epidemiology of female reproductive cancers in Mazandaran Province (Northern Iran): Results of the Mazandaran population-based cancer registry


, , , , , , , , , , , ,
Abstract

Purpose: Cancer is a most important disease, and female reproductive system cancers are the most common cause of women mortality rate. Materials and Methods: This cross-sectional study analyzed medical record data for 4460 patients in Mazandaran population-based cancer registry. Results: The mean (standard deviation) age of these patients was 53.45 years, and the incidence rate of female reproductive cancers (age-standardized incidence rate) was 8.51 per 100,000 persons-year. These cancers incidences were more in urban than rural, but this difference was not significant. Differences between frequency of uterus and ovary cancers with tumor behavior are significant (P = 0.046). Conclusion: This certainly calls for further attention to preventive and treatment planning on female reproductive system cancers.

Cite this article
Vancouver
Hedayatizadeh-Omran A, Alizadeh-Navaei R, Ashrafi M, Ghazizadeh Z, Mousavi R, Shekarriz R, et al. Epidemiology of female reproductive cancers in Mazandaran Province (Northern Iran): Results of the Mazandaran population-based cancer registry. Clin Cancer Investig J. 2018;7(3):87-9. https://doi.org/10.4103/ccij.ccij_11_18
APA
Hedayatizadeh-Omran, A., Alizadeh-Navaei, R., Ashrafi, M., Ghazizadeh, Z., Mousavi, R., Shekarriz, R., Jouybari, M., Zaboli, E., Janbabaei, G., Moradi, S., et al. (2018). Epidemiology of female reproductive cancers in Mazandaran Province (Northern Iran): Results of the Mazandaran population-based cancer registry. Clinical Cancer Investigation Journal, 7(3), 87-89. https://doi.org/10.4103/ccij.ccij_11_18

Copyright © 2024 Clinical Cancer Investigation Journal, All rights are reserved and for all open access contents, the Creative Commons licensing terms apply.
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513